These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

58 related articles for article (PubMed ID: 664472)

  • 1. [Effect of complex compounds of heparin with fibrinogen on the processes of fibrin formation].
    Potrebich AV; Danilina IA
    Vopr Med Khim; 1978; 24(3):404-7. PubMed ID: 664472
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Low-molecular heparin complex formation with the blood coagulation proteins--thrombin and fibrinogen].
    Kudriashov BA; Liapina LA; Pastorova VE; Kondashevskaia MV
    Izv Akad Nauk SSSR Biol; 1992; (5):802-6. PubMed ID: 1332992
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The heparin-dependent inhibition of the accumulation of 131J-fibrinogen in the solid form of Walker-256-carcinosarcoma of the rat (author's transl)].
    Heyes H; Köhle W
    Arch Geschwulstforsch; 1978; 48(8):712-7. PubMed ID: 753192
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Formation of a secondary adrenaline-heparin-fibrinogen complex and its properties].
    Kudriashov BA; Liapina LA; Zhitnikova ES; Obraztsov VV
    Vopr Med Khim; 1975; 21(1):65-9. PubMed ID: 1119113
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Presence of an active fibrinogen--heparin complex in the total blood plasma fraction of plasma fibrinogen degradation products].
    Kudriashov BA; Liapina LA; Ul'ianov AM
    Biokhimiia; 1977 Mar; 42(3):451-9. PubMed ID: 861306
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of standard heparin and a low molecular weight heparin on thrombolytic and fibrinolytic activity of single-chain urokinase plasminogen activator in vitro.
    Lourenço DM; Dosne AM; Kher A; Samama M
    Thromb Haemost; 1989 Nov; 62(3):923-6. PubMed ID: 2556812
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Electron microscopic study of the products from dissolving unstabilized fibrin with complex heparin compounds].
    Ul'ianov AM; Zhitnikova ES
    Biokhimiia; 1978; 43(4):646-52. PubMed ID: 656495
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Complex compounds of heparin in obstetric hemorrhages].
    Kudrjashov BA; Bloshansky UM; Polol'skaya OV; Lyapina LA; Kaverina KP; Spoludennaya ST
    Vopr Med Khim; 1975; 21(5):531-8. PubMed ID: 1082678
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fibrin formation: the role of the fibrinogen-fibrin monomer complex.
    Brass EP; Forman WB; Edwards RV; Lindan O
    Thromb Haemost; 1976 Aug; 36(1):37-48. PubMed ID: 1036827
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatocyte-derived fibrinogen-related protein-1 is associated with the fibrin matrix of a plasma clot.
    Rijken DC; Dirkx SP; Luider TM; Leebeek FW
    Biochem Biophys Res Commun; 2006 Nov; 350(1):191-4. PubMed ID: 16996032
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intraperitoneal fibrin-formation and its inhibition in CAPD.
    Gries E; Paar D; Graben N; Bock KD
    Clin Nephrol; 1986 Oct; 26(4):209-12. PubMed ID: 3780071
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Measurement of fibrinopeptide A in the evaluation of heparin activity and fibrin formation during hemodialysis.
    Wilhelmsson S; Asaba H; Gunnarsson B; Kudryk B; Robinson D; Bergström J
    Clin Nephrol; 1981 May; 15(5):252-8. PubMed ID: 7249422
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Analysis of lytic effect on fibrin of immobilized heparin in complex with plasma proteins].
    Platé NA; Valuev LI; Gumirova FKh; Maklakova IA
    Vopr Med Khim; 1982; 28(5):19-23. PubMed ID: 6217639
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fibrin formation inhibits the in vitro cytotoxic activity of human natural and lymphokine-activated killer cells.
    Gunji Y; Lewis J; Gorelik E
    Blood Coagul Fibrinolysis; 1990 Dec; 1(6):663-72. PubMed ID: 2133246
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The fibrinogenolytic activity of purified tryptase from human lung mast cells.
    Schwartz LB; Bradford TR; Littman BH; Wintroub BU
    J Immunol; 1985 Oct; 135(4):2762-7. PubMed ID: 3161948
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of fibrin coagulation in protection of murine tumor cells from destruction by cytotoxic cells.
    Gunji Y; Gorelik E
    Cancer Res; 1988 Sep; 48(18):5216-21. PubMed ID: 3409246
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Surface-adsorbed fibrinogen and fibrin may activate the contact activation system.
    Sanchez J; Elgue G; Larsson R; Nilsson B; Olsson P
    Thromb Res; 2008; 122(2):257-63. PubMed ID: 18177925
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The assembly and structure of the fibrin clot.
    Mosesson MW
    Nouv Rev Fr Hematol (1978); 1992; 34(1):11-6. PubMed ID: 1523091
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effects of three different heparin regimes on heparin concentrations in plasma and fibrin formation in dialyzers.
    Gunnarsson B; Asaba H; Dawidson S; Wilhelmsson S; Bergström J
    Clin Nephrol; 1981 Mar; 15(3):135-42. PubMed ID: 7273488
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of thrombin generation in plasma by fibrin formation (Antithrombin I).
    de Bosch NB; Mosesson MW; Ruiz-Sáez A; Echenagucia M; Rodriguez-Lemoin A
    Thromb Haemost; 2002 Aug; 88(2):253-8. PubMed ID: 12195697
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.